Investigation of possible aqueous phase formation during vaporization of sevoflurane

BACKGROUND AND AIMS: Ultane(®) (sevoflurane; AbbVie Inc., North Chicago, IL, USA) has a dissolved water content of approximately 0.035% weight/weight (w/w). A previous report described formation of an aqueous layer in 4 of 13 sevoflurane vaporizers used in operating rooms. We investigated the condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Varughese, Shane, Kalthod, Vikram G., Petzel, James P., Bacher, Hans Peter, Wallace, Arthur W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495606/
https://www.ncbi.nlm.nih.gov/pubmed/31057245
http://dx.doi.org/10.4103/joacp.JOACP_53_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495606/
https://www.ncbi.nlm.nih.gov/pubmed/31057245
http://dx.doi.org/10.4103/joacp.JOACP_53_18

Ejemplares similares